Screener
Sarepta Therapeutics, Inc. SRPT Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $198.23M.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
FAQ
- What is Sarepta Therapeutics, Inc.'s total debt?
- Sarepta Therapeutics, Inc. (SRPT) reported total debt of $198.23M in Q2 2026.
- How has Sarepta Therapeutics, Inc.'s total debt changed year-over-year?
- Sarepta Therapeutics, Inc.'s total debt decreased by 7.6% year-over-year, from $214.42M to $198.23M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s total debt?
- Over 5 years (2020 to 2025), Sarepta Therapeutics, Inc.'s total debt has grown at a 15.8% compound annual growth rate (CAGR), from $101.3M to $210.57M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Sarepta Therapeutics, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude